Mscripts introduces new mobile app platform features
SAN FRANCISCO — Users of Mscripts’ mobile pharmacy application platform will have a host of new features to make managing prescriptions and shopping easier, according to a presentation the company gave Friday at the Health Innovation Summit.
Mscripts announced that it would add new features to the platform that included integrated shopping lists, upgrades to the Mscripts coupon module and proxy prescription management that will allow one person to manage prescriptions for multiple family members. With the shopping list feature, users can add items to their list by browsing a store’s inventory, scanning barcodes, taking photos or typing in the product’s name. The upgraded coupon module will allow pharmacies to design and manage coupon campaigns and collect metrics, distributing coupons to shoppers on their phones through text or email messages.
"Pharmacies want to make the process of managing prescriptions and visiting the pharmacy more efficient for their customers," Mscripts CEO Mark Cullen said. "These features, combined with our robust couponing capabilities, save customers time and money."
Stop with the worry mongering. the answer to all or any of those issues is that the least regulation, most freedom doable, with a strict and powerful adherence to non-public property rights. power precision
Extraordinary mobile pharmacy application platform has created by Mscripts where this leading platform has been offering customer satisfactory and flexible with robust mobile pharmacy solution.Great strategies to make this more interactive among the customer by integrating shopping lists, upgrades to the Mscripts coupon module and proxy prescription management.Specially for pharmacies its an awesome mobile technology based platform.urgent care directory
Bristol-Myers Squibb donates $6.9 million to benefit cancer patients
PRINCETON, N.J. — Drug maker Bristol-Myers Squibb has donated $6.9 million to a nonprofit group that helps people pay for medical treatments, the company said.
Bristol made the donation to the HealthWell Foundation, which provides financial assistance to eligible people for covering co-insurance, co-payments, healthcare premiums and deductibles for certain treatments. The drug maker’s donation is targeted toward underinsured cancer patients.
"Bristol-Myers Squibb had robust patient assistance programs for cancer patients, and this contribution reinforces our commitment to helping patients gain access to the medicines they need," Bristol VP U.S. medical John Tsai said. "We are proud to support the HealthWell Foundation in its mission to reduce barriers to care for underinsured patients."
No comments found
NCPA seeks special enrollment period for Part D patients from CMS
ALEXANDRIA, Va. — The National Community Pharmacists Association is calling for the Centers for Medicare and Medicaid Services to allow senior patients to enroll in a new Medicare Part D prescription drug plan via a special enrollment period, particularly if patients believe that "material misrepresentations" led them to sign up for a "preferred network" plan with inadequate pharmacy access.
The NCPA said many patients claimed that at the time of enrollment, they relied on Medicare Plan Finder, the online portal maintained by the government agency, as well as online plan advertising and/or enrollment agents regarding the availability of low, advertised medication co-pays. Through misrepresentations from these sources, NCPA said, seniors have found themselves experiencing issues with access because when they visit their pharmacy of choice in the plan’s network, the advertised co-pays are not available because that provider is not one of the plan’s “preferred” pharmacies.
NCPA said it recently sent a letter to CMS asking the agency to agree to a special enrollment period for these patients this year and to take action to prevent similar, misleading marketing practices in future years. The letter also was accompanied by a compilation of problems patients and pharmacists are experiencing.
“NCPA previously warned that these overly restrictive Medicare drug plans were being deceptively marketed to patients and lack adequate pharmacy access for Americans in rural or underserved areas. While not surprising, it is unfortunate that our concerns were validated within the first few days of the 2012 plan year,” NCPA CEO B. Douglas Hoey said. “Now, seniors are going to the community pharmacy that they have relied on for years, sometimes decades, only to be told that they must travel 20 miles or more to obtain the lowest-advertised co-payments for their medication.
“While CMS is working with us to address individual patient concerns, we believe as a matter of fairness that all enrollees in these restrictive network plans should have the chance to reevaluate whether this is the right plan for them,” Hoey added. “Every day about 10,000 Americans turn 65 and are eligible to enroll in a Medicare drug plan. Medicare should allow seniors who feel that they’ve been duped the same choice as those just entering the program. In addition, CMS should implement preventative steps to avoid a repeat of this situation next year.”
No comments found